Liste über die Bewertung des regulatorischen Bedarfs
Liste über die Bewertung des regulatorischen Bedarfs
The assessment of regulatory needs list includes substances for which an assessment either is under development or has been completed.
For each substance, the table shows the assessing authority (submitter), the concern, the status and the suggested follow-up action, and the date of the latest update to the list entry.
Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.
Regulatory Management Option Analysis (RMOA) are assessments of regulatory needs. Publication of RMOA was initiated in February 2013 with the start of the implementation of the SVHC Roadmap. In 2019, authorities and in particular ECHA have moved to address more groups of substances.
The responsibility for the content of an assessment of regulatory needs rests with the authority that developed it. It is possible that other authorities do not have the same view and may develop a further assessment of regulatory needs for the same (group of) substances. Assessment of regulatory needs and their conclusions are compiled based on available information and may change in light of new information or further assessment.
Last updated 03 Mai 2024. Database contains 5017 unique substances/entries.
239-139-9
|
15087-24-8
|
Germany
|
Endocrine disruption |
Concluded
|
SVHC
|
10-Jul-2015
|
Details | |
covering any of its individual anti- and syn-isomers or any combination thereof
show/hide
(1S,2S,5R,6R,9S,10S,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene
EC / List no:
-
| CAS no:
135821-03-3
(1S,2S,5S,6S,9R,10R,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene
EC / List no:
-
| CAS no:
135821-74-8
1,6,7,8,9,14,15,16,17,17,18,18-dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene
EC / List no:
236-948-9
| CAS no:
13560-89-9
|
-
|
-
|
United Kingdom
|
Bioaccumulation Persistence |
Concluded
|
SVHC
|
10-Aug-2018
|
Details |
204-661-8
|
123-91-1
|
Germany
|
Bioaccumulation Persistence |
Concluded
|
SVHC Restriction |
17-Jun-2020
|
Details | |
214-317-9
|
1120-71-4
|
ECHA
|
Carcinogenic Mutagenic Toxic for reproduction |
Concluded
|
SVHC
|
06-Feb-2015
|
Details | |
214-946-9
|
1222-05-5
|
ECHA
|
Under development
|
CLH SVHC Pending action |
04-Mai-2023
|
Details | ||
271-094-0
|
68515-51-5
|
Sweden
|
Carcinogenic Mutagenic Toxic for reproduction |
Concluded
|
SVHC
|
13-Jan-2015
|
Details | |
253-692-3
|
37853-59-1
|
Spain
|
Bioaccumulation Endocrine disruption Persistence |
Concluded
|
SVHC Restriction |
21-Jul-2022
|
Details | |
253-242-6
|
36861-47-9
|
Germany
|
Endocrine disruption |
Concluded
|
SVHC
|
10-Jul-2015
|
Details | |
253-242-6
|
36861-47-9
|
Denmark
|
Endocrine disruption |
Concluded
|
SVHC
|
04-Dez-2020
|
Details | |
948-069-4
|
-
|
ECHA
|
Under development
|
CoRAP CLH SVHC |
04-Mai-2023
|
Details | ||
931-296-8
|
97862-59-4
|
ECHA
|
Under development
|
RMOA
|
16-Nov-2018
|
Details | ||
931-333-8
|
-
|
ECHA
|
Under development
|
RMOA
|
16-Nov-2018
|
Details | ||
931-513-6
|
-
|
ECHA
|
Under development
|
RMOA
|
16-Nov-2018
|
Details | ||
700-230-8
|
3160-86-9
|
ECHA
|
Under development
|
RMOA
|
13-Jan-2023
|
Details | ||
224-292-6
|
4292-10-8
|
ECHA
|
Under development
|
RMOA
|
16-Nov-2018
|
Details | ||
205-251-1
|
136-53-8
|
ECHA
|
Under development
|
Restriction
|
24-Nov-2023
|
Details | ||
Electrolytic solution from electrolysis of zinc sulfate consisting primarily of zinc sulfate, manganese oxides and sulfuric acid.
|
273-723-4
|
69012-24-4
|
ECHA
|
Under development
|
Restriction
|
02-Apr-2024
|
Details | |
show/hide
|
-
|
-
|
Germany
|
Carcinogenic Endocrine disruption Mutagenic Toxic for reproduction |
Concluded
|
Restriction
|
07-Dez-2017
|
Details |
237-159-2
|
13674-87-8
|
ECHA
|
Under development
|
CLH Restriction |
26-Jul-2022
|
Details | ||
228-150-4
|
6145-73-9
|
ECHA
|
Under development
|
CLH Restriction |
26-Jul-2022
|
Details | ||
204-118-5
|
115-96-8
|
ECHA
|
Under development
|
CLH Restriction |
26-Jul-2022
|
Details | ||
237-158-7
|
13674-84-5
|
ECHA
|
Under development
|
CLH Restriction |
26-Jul-2022
|
Details | ||
201-117-1
|
78-43-3
|
ECHA
|
Under development
|
CLH Restriction |
26-Jul-2022
|
Details | ||
239-487-1
|
15468-32-3
|
Netherlands
|
STOT RE |
Concluded
|
Restriction Other legislation |
10-Mär-2023
|
Details | |
206-203-2
|
307-55-1
|
Germany
|
Bioaccumulation Persistence Toxic for reproduction |
Concluded
|
Restriction
|
07-Mär-2017
|
Details | |
238-009-9
|
14166-21-3
|
ECHA
|
Under development
|
Restriction
|
19-Feb-2021
|
Details | ||
206-108-6
|
301-10-0
|
ECHA
|
Under development
|
Restriction
|
24-Mai-2023
|
Details | ||
272-388-1
|
68815-67-8
|
ECHA
|
Under development
|
Restriction
|
31-Mär-2023
|
Details | ||
203-726-8
|
109-99-9
|
Germany
|
Consumer use |
Concluded
|
CLH Restriction |
20-Sep-2022
|
Details | |
246-563-8
|
25013-16-5
|
France
|
Endocrine disruption |
Concluded
|
Restriction
|
30-Jan-2015
|
Details | |
-
|
-
|
France
|
Carcinogenic Mutagenic Other human toxicity Toxic for reproduction |
Concluded
|
Restriction
|
12-Nov-2019
|
Details | |
Substances manufactured in form of fibres with length ≥ 5 µm, a diameter < 3 µm and aspect ratio ≥ 3:1 as well as fibres released from substances, mixtures or articles during their life cycle due to mechanical effects (e.g. breaking/splicing), chemical processes (e.g. oxidation/ageing) or physical conditions (e.g. heat), excluding asbestos
|
-
|
-
|
Germany
|
Carcinogenic |
Concluded
|
Restriction
|
30-Mai-2023
|
Details |
219-536-3
|
2457-02-5
|
ECHA
|
Under development
|
Restriction
|
24-Nov-2023
|
Details | ||
243-283-8
|
19766-89-3
|
ECHA
|
Under development
|
Restriction
|
24-Nov-2023
|
Details | ||
Substance formed during processing of liquid steel or during production of iron castings. Consists primarily of fused silicates and trace elements as oxides as well as trace of alloying elements.
|
294-409-3
|
91722-09-7
|
ECHA
|
Under development
|
Restriction
|
29-Nov-2023
|
Details | |
The fused substance formed by the action of a flux upon the gangue of iron-bearing materials charged to a steelmaking furnace and upon the oxidized impurities in the steel produced. Depending upon the particular steelmaking operation, the slag is composed primarily of sulfur and oxides of aluminum, calcium, iron, magnesium, manganese, phosphorus, and silicon.
|
266-004-1
|
65996-71-6
|
ECHA
|
Under development
|
Restriction
|
29-Nov-2023
|
Details | |
By-product of the manufacture of silicomanganese alloy containing oxides of aluminum, calcium, magnesium, manganese and silicon.
|
273-733-9
|
69012-33-5
|
ECHA
|
Under development
|
Restriction
|
29-Nov-2023
|
Details | |
Substance formed by processing of chiefly oxidic material with lead and zinc content in a rotating furnace. Consists primarily of Al2O3, CaO, Fe, FeO and SiO2 with other nonferrous compounds as well as carbon.
|
297-907-9
|
93763-87-2
|
ECHA
|
Under development
|
Restriction
|
29-Nov-2023
|
Details | |
Slag formed as the feed progresses through the blast furnace in lead smelting. Consists primarily of metallic elements and oxides of calcium, magnesium and silicon.
|
273-825-9
|
69029-84-1
|
ECHA
|
Under development
|
Restriction
|
29-Nov-2023
|
Details | |
The fused substance formed by the action of a flux upon the gangue of the iron-bearing materials charged to a blast furnace and upon the oxidized impurities in the iron produced. Depending upon the particular blast furnace operation, the slag is composed primarily of sulfur and oxides of aluminum, calcium, magnesium, and silicon.
|
266-002-0
|
65996-69-2
|
ECHA
|
Under development
|
Restriction
|
29-Nov-2023
|
Details | |
By-product of the manufacture of ferromanganese alloy containing primarily oxides of aluminum, manganese and silicon.
|
273-728-1
|
69012-28-8
|
ECHA
|
Under development
|
Restriction
|
29-Nov-2023
|
Details | |
701-265-1
|
-
|
ECHA
|
Under development
|
Restriction
|
29-Nov-2023
|
Details | ||
show/hide
|
-
|
-
|
Sweden
|
Skin sensitiser |
Concluded
|
Restriction
|
02-Feb-2017
|
Details |
946-132-0
|
-
|
ECHA
|
Under development
|
Restriction
|
13-Jul-2022
|
Details | ||
807-935-0
|
1244733-77-4
|
ECHA
|
Under development
|
CLH Restriction |
26-Jul-2022
|
Details | ||
428-050-2
|
-
|
ECHA
|
Under development
|
Restriction
|
18-Feb-2022
|
Details | ||
911-815-4
|
-
|
ECHA
|
Under development
|
CLH Restriction |
26-Jul-2022
|
Details | ||
903-161-3
|
-
|
ECHA
|
Under development
|
Restriction
|
31-Mär-2023
|
Details | ||
946-797-7
|
-
|
ECHA
|
Under development
|
Restriction
|
13-Jul-2022
|
Details | ||
906-378-1
|
-
|
ECHA
|
Under development
|
Restriction
|
13-Jul-2022
|
Details | ||